[go: up one dir, main page]

WO1996006639A3 - Nouveaux medicaments contenant des agents formant des chelates - Google Patents

Nouveaux medicaments contenant des agents formant des chelates Download PDF

Info

Publication number
WO1996006639A3
WO1996006639A3 PCT/EP1995/003426 EP9503426W WO9606639A3 WO 1996006639 A3 WO1996006639 A3 WO 1996006639A3 EP 9503426 W EP9503426 W EP 9503426W WO 9606639 A3 WO9606639 A3 WO 9606639A3
Authority
WO
WIPO (PCT)
Prior art keywords
novel drugs
forming agents
drugs containing
containing chelate
bivalent
Prior art date
Application number
PCT/EP1995/003426
Other languages
German (de)
English (en)
Other versions
WO1996006639A2 (fr
Inventor
Serban Al Bacanu
Iulian Ionescu
Sorin Sarzea
Stefan Teodor Tomas
Original Assignee
Medico Pharma Vertriebs Gmbh
Sicomed Sa
Serban Al Bacanu
Iulian Ionescu
Sorin Sarzea
Stefan Teodor Tomas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medico Pharma Vertriebs Gmbh, Sicomed Sa, Serban Al Bacanu, Iulian Ionescu, Sorin Sarzea, Stefan Teodor Tomas filed Critical Medico Pharma Vertriebs Gmbh
Priority to AU35194/95A priority Critical patent/AU3519495A/en
Publication of WO1996006639A2 publication Critical patent/WO1996006639A2/fr
Publication of WO1996006639A3 publication Critical patent/WO1996006639A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/30—Copper compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/315—Zinc compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne de nouveaux médicaments contenant des agents formant des chélates ainsi que des acides aminés essentiels ou leurs dérivés, complexés le cas échéant avec des ions métalliques bivalents. Ces nouveaux médicaments contiennent en outre des éléments bivalents ou des composés d'éléments bivalents.
PCT/EP1995/003426 1994-09-01 1995-08-31 Nouveaux medicaments contenant des agents formant des chelates WO1996006639A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU35194/95A AU3519495A (en) 1994-09-01 1995-08-31 Novel drugs containing chelate-forming agents

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19944431175 DE4431175A1 (de) 1994-09-01 1994-09-01 Neue, Chelatbildner enthaltende Arzneimittel
DEP4431175.3 1994-09-01

Publications (2)

Publication Number Publication Date
WO1996006639A2 WO1996006639A2 (fr) 1996-03-07
WO1996006639A3 true WO1996006639A3 (fr) 1996-07-25

Family

ID=6527188

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1995/003426 WO1996006639A2 (fr) 1994-09-01 1995-08-31 Nouveaux medicaments contenant des agents formant des chelates

Country Status (3)

Country Link
AU (1) AU3519495A (fr)
DE (1) DE4431175A1 (fr)
WO (1) WO1996006639A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6887996A (en) * 1995-09-01 1997-04-01 Washington University School Of Medicine Method of reducing neurotoxic injury with zinc chelators
DE19641197C2 (de) * 1996-09-24 1999-02-18 Schering Ag Ionenpaare und ihre Verwendung als Kontrastmittel
ATE444760T1 (de) * 1997-01-13 2009-10-15 Univ Emory Glutathion zur behandlung von influenzainfektionen
DE19735126C1 (de) * 1997-08-13 1999-01-21 Infectopharm Arzneimittel Und Verfahren zur Herstellung einer eine Zinkverbindung enthaltenden oralen Zusammensetzung und deren Verwendung zur Behandlung von Erkältungskrankheiten
US6103748A (en) * 1998-06-19 2000-08-15 Bryan; Thomas B. Method of treating an autoimmune disorder
ES2216709B1 (es) * 2003-04-08 2005-08-01 Mercedes Nubia Perez De Cabrales Composicion farmaceutica para tratar el herpes zoster.
RU2008106419A (ru) * 2008-02-21 2009-08-27 Закрытое акционерное общество "Ива фарм" (RU) Лекарственные средства на основе олигоядерных координационных соединений d-металлов, способ терапевтического воздействия на организм пациента и способ повышения терапевтической эффективности фармакологически активного вещества
MX2018002985A (es) * 2018-03-09 2019-09-10 Inst Tecnologico Jose Mario Molina Pasquel Y Henriquez Complejos bimetalicos con cationes divalentes con efecto inhibidor de la replicacion del vhs.

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2827478A1 (de) * 1978-06-22 1980-01-17 Jozsef Dr Beres Arzneimittel, insbesondere zur heilung von und vorbeugung gegen geschwulstkrankheiten
WO1983002893A1 (fr) * 1982-02-23 1983-09-01 Dinu, Romulus, Constantin Composition medicinale pour le traitement de certaines nevroviroses
WO1992015329A1 (fr) * 1991-02-28 1992-09-17 The United States Of America, Represented By The Secretary, United States Department Of Commerce Procedes et compositions pharmaceutiques servant a inhiber la protease du virus de l'immunodeficience humaine
WO1994022438A1 (fr) * 1993-03-26 1994-10-13 Constantin Romulus Dinu Composition pharmaceutique destinee au traitement de certains virus et de certaines maladies auto-immunes, et son procede de preparation

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2827478A1 (de) * 1978-06-22 1980-01-17 Jozsef Dr Beres Arzneimittel, insbesondere zur heilung von und vorbeugung gegen geschwulstkrankheiten
WO1983002893A1 (fr) * 1982-02-23 1983-09-01 Dinu, Romulus, Constantin Composition medicinale pour le traitement de certaines nevroviroses
WO1992015329A1 (fr) * 1991-02-28 1992-09-17 The United States Of America, Represented By The Secretary, United States Department Of Commerce Procedes et compositions pharmaceutiques servant a inhiber la protease du virus de l'immunodeficience humaine
WO1994022438A1 (fr) * 1993-03-26 1994-10-13 Constantin Romulus Dinu Composition pharmaceutique destinee au traitement de certains virus et de certaines maladies auto-immunes, et son procede de preparation

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DINU R ET AL: "Chelatotherapy in multiple sclerosis. Open preliminary study of a new therapeutical principle applied in multiple sclerosis--public health topic.", SANTE PUBLIQUE (BUCUR), 1985, 28 (1) P3-30, ROMANIA, XP002002402 *
DINU R ET AL: "Herpes zoster and herpes simplex--public health matter;chelatotherapy in these acute neuroviroses.", SANTE PUBLIQUE (BUCUR), 1984, 27 (2) P99-114, ROMANIA, XP002002401 *
DINU R ET AL: "Rodilemid therapy in peripheral palsy: a clinical and electrophysiological study.", NEUROL PSYCHIATR (BUCUR), OCT-DEC 1986, 24 (4) P263-8, ROMANIA, XP002002404 *
R. DINU ET AL.: "Chelatotherapy with Rodilemid in some acute neuroviroses and multiple sclerosis", NEUROL. PSYCHIATR. REV. ROUM. MED., vol. 21, no. 3, 1983, pages 307 - 308, XP002002403 *
ST. AGRIGOROAEI ET AL.: "Specific action of some biosynthesis products upon the body's defence capacity", REV. ROUM. BIOL. SER. BIOL. ANIM., vol. 34, no. 2, 1989, pages 129 - 132, XP002002405 *

Also Published As

Publication number Publication date
AU3519495A (en) 1996-03-22
WO1996006639A2 (fr) 1996-03-07
DE4431175A1 (de) 1996-04-11

Similar Documents

Publication Publication Date Title
CA2234282A1 (fr) Complexes medicament/resine stabilises par des chelateurs
NZ296474A (en) Amino acid derivative which maintains or increases cellular drug sensitivity
IL110455A0 (en) Pharmaceutical compositions for preventing the development of restenosis or intimal hyperplasia
AU674358B2 (en) Novel 1,2-benzoisoxazole derivative or its salt and brain -protecting agent comprising the same
ZA9811507B (en) Combination effective for the treatment of impotence.
EP0614944A3 (fr) Composition intumescente du type deux-composantes.
MXPA00012647A (es) Derivados n-sustituidos de acido 5-oxiiminobarbiturico.
WO2001010408A3 (fr) Composition pharmaceutique aqueuse a base de moxifloxacine ou de ses sels
ZA965922B (en) Preparation of N-substituted 3-hydroxypyrazoles.
WO1996006639A3 (fr) Nouveaux medicaments contenant des agents formant des chelates
CA2287838A1 (fr) Radionuclide associe a un polyphosphate nucleotidique en tant qu'agents d'imagerie de tumeurs
ZA933151B (en) Cycloheptimidazole derivatives, method of manufacturing the same and therapeutic agents containing these compounds.
EP0663209A3 (fr) Médicament pour inhiber les effets des protéines amyloidogéniques.
EP0641776A3 (fr) Dérivés de thioglycérol.
ZA963744B (en) Topical aciclovir preparation
EP0618222A3 (en) Dipeptid derivatives of 5-amino-4-hydroxy-hexanoic acid.
AU3737289A (en) Agent for treating pancreatitis or the like
WO1999033451A3 (fr) Melange et composition pharmaceutique comprenant du z-4- hydroxytamoxifene et de la cyclodextrine
EP0663816A4 (fr) Classe nouvelle de derives de phosphocholine a activite fongicide.
GB9315183D0 (en) Biosensors
AU9240898A (en) Process for the modification of toxic and/or off-flavoured compounds
WO2001002363A3 (fr) Derives de glycine n-substitues
IE820987L (en) Esters of n-substituted amino acids
EP0641764A3 (fr) Procédé pour la préparation de dérivés d'hydroxyalkylaminonitrobenzène.
ZA945190B (en) Carboxymethylidenecycloheptimidazole derivatives method or manufacturing the same and therapeutic agents containing these compounds

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AM AT AU BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TT UA UG US UZ VN

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): KE MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642